Biomay Offers Lipid-Nanoparticle Formulation Services for RNA Pharmaceuticals
(March 4th, 2025) Biomay now offers GMP services for lipid-based nanoparticles (LNPs). With this, the company has completed its end-to-end platform for manufacturing of GMP-grade mRNA drugs from scratch. A comprehensive list of LNP-specific and GMP-conform analytical assays support that service offering …
> More info